CO2022000278A2 - Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella - Google Patents

Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella

Info

Publication number
CO2022000278A2
CO2022000278A2 CONC2022/0000278A CO2022000278A CO2022000278A2 CO 2022000278 A2 CO2022000278 A2 CO 2022000278A2 CO 2022000278 A CO2022000278 A CO 2022000278A CO 2022000278 A2 CO2022000278 A2 CO 2022000278A2
Authority
CO
Colombia
Prior art keywords
compositions
prevotella
methods
mediated condition
treating
Prior art date
Application number
CONC2022/0000278A
Other languages
English (en)
Spanish (es)
Inventor
Taylor A Cormack
Andrea Itano
Holly Ponichtera
Kritika Ramani
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of CO2022000278A2 publication Critical patent/CO2022000278A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CONC2022/0000278A 2019-06-21 2022-01-17 Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella CO2022000278A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962864886P 2019-06-21 2019-06-21
US201962910920P 2019-10-04 2019-10-04
PCT/US2020/038335 WO2020257390A1 (en) 2019-06-21 2020-06-18 Compositions and methods of treating a th2-mediated condition using prevotella

Publications (1)

Publication Number Publication Date
CO2022000278A2 true CO2022000278A2 (es) 2022-01-28

Family

ID=71950833

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0000278A CO2022000278A2 (es) 2019-06-21 2022-01-17 Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella

Country Status (11)

Country Link
EP (1) EP3986431A1 (pt)
JP (1) JP2022536861A (pt)
KR (1) KR20220024684A (pt)
CN (1) CN114245742A (pt)
AU (1) AU2020297498A1 (pt)
BR (1) BR112021025676A2 (pt)
CA (1) CA3143994A1 (pt)
CO (1) CO2022000278A2 (pt)
MX (1) MX2021016034A (pt)
TW (1) TW202120109A (pt)
WO (1) WO2020257390A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022061141A1 (en) * 2020-09-21 2022-03-24 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
TW202227110A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 用棲組織普雷沃菌調節免疫反應之組成物及方法
JP2024505207A (ja) * 2021-01-26 2024-02-05 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）細胞外小胞調製物
WO2022182707A1 (en) * 2021-02-26 2022-09-01 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (en) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
CN113509494A (zh) * 2021-09-06 2021-10-19 南京医科大学 普氏菌在制备治疗胆汁淤积性疾病的药物中的应用
CN114028503A (zh) * 2021-12-08 2022-02-11 刘斌 治疗过敏性鼻炎的中西药配方及应用
WO2023146843A1 (en) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023200837A1 (en) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023239728A1 (en) * 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
CN115364223A (zh) * 2022-08-17 2022-11-22 郑州可尔利尔生物科技有限公司 作用于stat 6靶点的物质成分在制备治疗慢性瘙痒症的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003908A1 (en) * 2015-11-03 2017-05-11 The Brigham And Women's Hospital, Inc. Therapeutic microbiota for the treatment and/or prevention of food allergy
EP3423093A4 (en) * 2016-03-04 2019-11-13 The Regents of The University of California MICROBIAL CONSORTIUM AND USES THEREOF
US20190240263A1 (en) * 2017-09-08 2019-08-08 Evelo Biosciences, Inc. Extracellular Vesicles From Prevotella

Also Published As

Publication number Publication date
WO2020257390A1 (en) 2020-12-24
CN114245742A (zh) 2022-03-25
JP2022536861A (ja) 2022-08-19
MX2021016034A (es) 2022-02-21
CA3143994A1 (en) 2020-12-24
EP3986431A1 (en) 2022-04-27
BR112021025676A2 (pt) 2022-05-17
TW202120109A (zh) 2021-06-01
AU2020297498A1 (en) 2022-01-20
KR20220024684A (ko) 2022-03-03

Similar Documents

Publication Publication Date Title
CO2022000278A2 (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella
CO2022002413A2 (es) Composiciones y métodos para tratar la psoriasis y la dermatitis atópica usando prevotella histicola
CO2020007142A2 (es) Composiciones y métodos para el tratamiento de los trastornos inmunitarios utilizando cepas de bacterias inmunomoduladoras de lactococcus
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
MX2021006581A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
MX2016009898A (es) Tratamientos para acne resistente.
CO2020010956A2 (es) Composiciones y métodos para el tratamiento del cáncer y de trastornos inmunitarios usando bacterias de veillonella
CL2020000770A1 (es) Tratamiento del virus del mosaico e infecciones bacterianas de plantas.
AR113881A1 (es) Composiciones y métodos para el tratamiento de desórdenes inmunes usando la cepa blautia
CO2017007694A2 (es) Composiciones de bacillus licheniformis rti184 para beneficiar el crecimiento de plantas
GB2535666A (en) Antimicrobial compositions
BR112018068593A2 (pt) composições tópicas não aquosas que compreendem uma salicilanilida halogenada
BR112017010808A2 (pt) prevenção e tratamento de infecções microbianas
BR112018068079A2 (pt) método para cultivar uma planta, agente de ativação para plantas, e composição de agente de ativação de plantas
CL2020002679A1 (es) Composiciones para el tratamiento de condiciones a la piel
UY36332A (es) Composiciones de bacillus pumilus rt1279 y metodos de uso para benefficiar el crecimiento de las plantas
AR115081A1 (es) Aislados de microbacterias y sus usos
CL2017001329A1 (es) Conjunto bacteriano sinergístico destinado a movilizar el fósforo del suelo.
MX2016015804A (es) Composiciones antimicrobianas que utilizan plata y oxigeno, proceso para elaborarlas y metodo para utilizarlas.
UY36273A (es) Composicion para el tratamiento de neuropatías y del dolor neuropático
AR119220A1 (es) Composiciones y métodos de tratamiento de un estado mediado por th2 usando prevotella
AR107460A1 (es) Gabapentina oftálmica para el tratamiento de las úlceras corneales
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
CO2021014747A2 (es) Métodos para el tratamiento de βeta-talasemia
CL2017000983A1 (es) Método para el control de patógenos microbiales en tejido vegetal vivo